Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.
Bao, in collaboration with Baylor College of Medicine, Texas Children’s Hospital and Stanford University, is working to find a cure for the hereditary disease. A single DNA mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.
In his talk at the annual American Association for the Advancement of Science meeting in Austin Feb. 16, Bao revealed results from a series of tests to see whether CRISPR/Cas9-based editing can fix the mutation. His presentation was part of a scientific session titled “Gene Editing and Human Identity: Promising Advances and Ethical Challenges.”
“Sickle cell disease is caused by a single mutation in the beta-globin gene (in the stem cell’s DNA),” he said. “The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells. Those will then be healthy blood cells.”
The findings, part of an upcoming paper, are a step toward treating sickle cell disease. Obstacles in the way of a cure include optimizing the CRISPR/Cas9 system to eliminate off-target effects, as well as finding a way to further increase the amount of gene-corrected stem cells.
Bao pointed out that researchers still don’t know whether repairing as much as 40 percent of the cells is enough to cure a patient. “We’d like to say, ‘Yes,’” he said, “but we don’t really know yet. That’s something we hope to learn from an eventual clinical trial.”
The Latest on: Sickle cell
[google_news title=”” keyword=”Sickle cell” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Sickle cell
- New Sickle Cell Disease Drug Approved For Use In England Here's How Voxelotor Workson May 9, 2024 at 12:15 pm
A drug that can treat severe sickle cell disease has recently been given approval by the National Institute for Health and Care Excellence (Nice). U ...
- Tricuspid regurgitation velocity tied to kidney, cerebrovascular disease in children with sickle cell disease: Studyon May 9, 2024 at 8:45 am
Evidence from the study revealed pediatric patients with a history of cerebrovascular disease (CVD) and chronic kidney disease (CKD) showed a higher prevalence of abnormal TRV, indicating the need for ...
- Couples in 3 Kenyan Regions Asked to Screen for Sickle Cell Disease Before Marriage, Getting Babieson May 9, 2024 at 7:18 am
Health experts say sickle cell disease is common in the western, coastal, and lake regions of Kenya. Testing helps reduce risk of birthing children with condition.
- Local doctor breaks down sickle cell disease in wake of Justin Johnson's deathon May 8, 2024 at 3:52 pm
Justin Johnson’s death has sparked a lot of online conversations about sickle cell disease. The Centers for Disease Control and Prevention reports approximately 100,000 Americans are affected by the ...
- May 18 brunch will offer sickle cell disease support in Albany areaon May 8, 2024 at 2:02 pm
The MTS Sickle Cell Foundation has partnered with the Georgia Public Library Service and the Dougherty County Library System to help raise awareness about sickle cell disease in the community. The ...
- Black 12-Year-Old Patient Begins New Sickle Cell Therapy Treatmenton May 7, 2024 at 8:39 am
A 12-year-old Black patient is the first to undergo a new gene therapy treatment for sickle cell disease, according to reports.
- What is sickle cell disease, the illness that led to a 16-year-old's death?on May 6, 2024 at 6:46 pm
After a 16-year-old Dauphin County boy died suddenly, the coroner determined his cause of death was complications from sickle cell disease. It has some people wondering: What is this illness? Sickle ...
- A 12-Year-Old Is First to Start New Sickle Cell Treatmenton May 6, 2024 at 1:25 pm
He's the first patient outside of a clinical trial to start a new genetic treatment that was shown in clinical trials to cure 88% of people of the hallmark symptoms of sickle cell disease.
- First sickle cell patients begin gene therapy treatments by bluebird bio, Vertexon May 6, 2024 at 8:47 am
Five months after bluebird bio Inc. won FDA approval for its gene therapy to treat sickle cell disease, the Somerville company said its first patient has begun treatment.
- First Patient Begins Newly Approved Sickle Cell Gene Therapyon May 6, 2024 at 4:01 am
A 12-year-old boy in the Washington, D.C., area faces months of procedures to remedy his disease. “I want to be cured,” he said.
via Bing News